BOOKS BY CATEGORY
Your Account
Green's Child and Adolescent Clinical Psychopharmacology
Price
Quantity
£85.00
(To see other currencies, click on price)
Paperback / softback
Add to basket  

£70.99
(To see other currencies, click on price)
Add to basket  

MORE ABOUT THIS BOOK

Main description:

 The ideal quick reference for the busy mental health clinician seeing younger patients, the Fifth Edition of Green’s Child and Adolescent Clinical Psychopathology has been fully revised by a new team of authors active in clinical practice and resident education.  A trusted reference in the field, Green’s continues to provide practical and balanced information on the full range of medications used to treat mental health disorders in children and adolescents.

 This rapid reference delivers…
• Detailed coverage of medication usage—including both FDA-approved and evidence-based off-label uses.
• Precautions and warnings help readers avoid prescribing errors and adverse drug interactions.
• Emphasis on recent and highly used medications, with older and less often used agents grouped in an Appendix.
• Convenient, reader-friendly organization makes essential information easy to find and use.

 NEW to the Fifth Edition…
• Increased focus on medication effects and cost-effectiveness
• New information on cardiac function and risk factors in patients taking stimulants
• Long-term suicide risks associated with SSRIs
• Longer term outcomes of major depression treatment
• Use of anticonvulsant medications in patients with bipolar disorder
• Weight gain in patients taking antipsychotics


PRODUCT DETAILS

ISBN-13: 9781451107142
Publisher: Lippincott Williams & Wilkins
Publication date: October, 2013
Pages: 416
Weight: 2g
Availability: Available
Subcategories: Psychiatry
Related books
Publisher recommends

CUSTOMER REVIEWS

Average Rating 

"This is a practical and quick reference for clinicians treating children and adolescents with psychiatric disorders. The authors' practical approach, organization, and clarity make it easy to read. Since the 2006 edition, several new psychotropic medications have come on the market and there have been new FDA approvals as well as ongoing research on the use of older medications for several conditions. This is an important contribution to the field of child psychopharmacology and is worthy of a place in any clinician's library." - Seleena M. Shrestha, MD, Rush University Medical Center, on belaf of Doody's Review Service